Inpp5d Phenotype Annotations

Mammalian Phenotype Ontology Annotations
Query Results - Summary

Symbol
Name
ID

Inpp5d
inositol polyphosphate-5-phosphatase D
MGI:107357

121 phenotypes from 13 alleles in 18 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Cd79a^tm1(cre)Reth/Cd79a⁺ Inpp5d^tm1Rav/Inpp5d^tm1Rav involves: 129 * BALB/c * C57BL/6	increased anti-chromatin antibody level	J:178833
	increased anti-double stranded DNA antibody level	J:178833
	increased anti-nuclear antigen antibody level	J:178833
	increased anti-single stranded DNA antibody level	J:178833
	increased autoantibody level	J:178833
	increased IgG level	J:178833
	increased susceptibility to systemic lupus erythematosus	J:178833
	premature death	J:178833
Inpp5d^el20/Inpp5d^el20 B6.129-Inpp5d^el20	abnormal erythropoiesis	J:173266
	abnormal lymphocyte cell number	J:173266
	abnormal pulmonary alveolus morphology	J:173266
	anemia	J:173266
	decreased body size	J:173266
	decreased lymphocyte cell number	J:173266
	decreased pre-B cell number	J:173266
	decreased thymocyte number	J:173266
	enlarged spleen	J:173266
	increased circulating interleukin-6 level	J:173266
	increased IgG2a level	J:173266
	increased IgM level	J:173266
	increased immunoglobulin level	J:173266
	increased macrophage cell number	J:173266
	postnatal growth retardation	J:173266
	premature death	J:173266
	respiratory failure	J:173266
	small thymus	J:173266
	thrombocytopenia	J:173266
Inpp5d^m1Anu/Inpp5d^m1Anu C57BL/6JAnu-Inpp5d^m1Anu	increased B cell derived lymphoma incidence	J:104190
	lung hemorrhage	J:104190
	lung inflammation	J:104190
Inpp5d^m1Btlr/Inpp5d^m1Btlr C57BL/6J-Inpp5d^m1Btlr	abnormal B cell differentiation	J:140987
	abnormal eosinophil physiology	J:140987
	abnormal neutrophil physiology	J:140987
	cachexia	J:140987
	decreased cytotoxic T cell cytolysis	J:140987
	enlarged spleen	J:140987
	enlarged thymus	J:140987
	impaired natural killer cell mediated cytotoxicity	J:140987
	premature death	J:140987
Inpp5d^m2Btlr/Inpp5d^m2Btlr C57BL/6J-Inpp5d^m2Btlr	decreased B cell number	J:216053
Inpp5d^M3Btlr/Inpp5d⁺ C57BL/6J-Inpp5d^M3Btlr	decreased NK cell number	J:254907
Inpp5d^m4Btlr/Inpp5d^m4Btlr C57BL/6J-Inpp5d^m4Btlr	increased interferon-beta secretion	J:272854
Inpp5d^m4Btlr/Inpp5d^m4Btlr C57BL/6J-Inpp5d^m4Btlr	increased tumor necrosis factor secretion	J:272854
Inpp5d^m5Btlr/Inpp5d^m5Btlr C57BL/6J-Inpp5d^m5Btlr	abnormal CD8-positive, alpha-beta T cell differentiation	J:272856
	abnormal lymphocyte morphology	J:272856
	abnormal T cell differentiation	J:272856
	decreased alpha-beta T cell number	J:272856
	decreased B cell number	J:272856
	decreased body weight	J:272856
	decreased CD4-positive, alpha-beta T cell number	J:272856
	decreased CD8-positive, alpha-beta T cell number	J:272856
	decreased CD8-positive, naive alpha-beta T cell number	J:272856
	decreased heart rate	J:272856
	decreased NK cell number	J:272856
	increased B-1 B cell number	J:272856
	increased CD8-positive, alpha-beta T cell number	J:272856
	increased central memory CD8 positive, alpha-beta T cell number	J:272856
	increased effector memory CD4-positive, alpha-beta T cell number	J:272856
	increased effector memory CD8-positive, alpha-beta T cell number	J:272856
Inpp5d^tm1.1Wgk/Inpp5d^tm1.1Wgk involves: 129S6/SvEvTac * C57BL/6J	abnormal leukocyte physiology	J:94861
	abnormal mononuclear cell differentiation	J:94861
	abnormal NK cell morphology	J:95215
	decreased susceptibility to graft versus host disease	J:94861, J:95215
	increased dendritic cell number	J:94861
	increased monocyte cell number	J:94861
	increased NK cell number	J:95215
Inpp5d^tm1Dmt/Inpp5d^tm1Dmt B6.129P2/OlaHsd-Inpp5d^tm1Dmt	abnormal pulmonary alveolus morphology	J:173266
	anemia	J:173266
	decreased lymphocyte cell number	J:173266
	decreased pre-B cell number	J:173266
	increased circulating interleukin-6 level	J:173266
	premature death	J:173266
	respiratory failure	J:173266
	thrombocytopenia	J:173266
Inpp5d^tm1Dmt/Inpp5d^tm1Dmt involves: 129P2/OlaHsd	abnormal leukocyte physiology	J:77739
	decreased B cell number	J:77739
	enlarged lymph nodes	J:77739
	enlarged spleen	J:77739
	increased leukocyte cell number	J:77739
	premature death	J:77739
Inpp5d^tm1Dmt/Inpp5d^tm1Dmt involves: 129P2/OlaHsd * C57BL/6	abnormal blood coagulation	J:121283
	abnormal platelet activation	J:121283
	decreased platelet aggregation	J:121283
	increased bleeding time	J:121283
Inpp5d^tm1Rav/Inpp5d^tm1.1Rav Lyz2^tm1(cre)Ifo/Lyz2⁺ involves: 129P2/OlaHsd * C57BL/6	abnormal spleen marginal zone macrophage morphology	J:119256
	absent marginal zone B cells	J:119256
	enlarged spleen	J:119256
Inpp5d^tm1Rav/Inpp5d^tm1Rav Tg(Cd4-cre)1Cwi/? involves: C57BL/6 * DBA/2	abnormal cytotoxic T cell physiology	J:122796
	abnormal humoral immune response	J:122796
	abnormal interferon level	J:122796
	abnormal interleukin secretion	J:122796
	abnormal lymph node germinal center morphology	J:122796
	decreased susceptibility to parasitic infection	J:122796
Inpp5d^tm1Rkh/Inpp5d^tm1Rkh involves: 129S1/Sv * 129X1/SvJ	abnormal bone marrow cell physiology	J:110864
	abnormal bone structure	J:78771
	abnormal CD4-positive, alpha-beta T cell physiology	J:110864
	abnormal CD8-positive, alpha-beta T cell physiology	J:110864
	abnormal cell-mediated immunity	J:110864
	abnormal long bone metaphysis morphology	J:78771
	abnormal long bone morphology	J:78771
	abnormal macrophage chemotaxis	J:110864
	abnormal osteoclast differentiation	J:78771
	abnormal osteoclast morphology	J:78771
	abnormal osteoclast physiology	J:78771
	abnormal skeleton morphology	J:78771
	abnormal skeleton physiology	J:78771
	abnormal T cell physiology	J:110864
	abnormal trabecular bone morphology	J:78771
	decreased apoptosis	J:78771
	decreased bone mineral density	J:78771
	decreased bone strength	J:78771
	decreased bone trabecula number	J:78771
	decreased compact bone thickness	J:78771
	decreased trabecular bone thickness	J:78771
	decreased trabecular bone volume	J:78771
	enhanced B cell migration	J:110864
	increased circulating interleukin-6 level	J:78771
	increased mast cell degranulation	J:120426
	increased osteoclast cell number	J:78771
	pulmonary edema	J:100868
	short femur	J:78771
Inpp5d^tm1Rkh/Inpp5d^tm1Rkh involves: 129S1/Sv * 129X1/SvJ * C57BL/6	abnormal ileum morphology	J:173301
	abnormal interleukin level	J:173301
	abnormal intestinal goblet cell morphology	J:173301
	abnormal intestinal smooth muscle morphology	J:173301
	abnormal intestine morphology	J:173301
	abnormal myelopoiesis	J:117320
	decreased pro-B cell number	J:117320
	ileum inflammation	J:173301
	increased circulating interleukin-6 level	J:117320
	intestinal inflammation	J:173301
Inpp5d^tm1Rkh/Inpp5d^tm1Rkh involves: 129S1/Sv * 129X1/SvJ * C57BL/6J	abnormal definitive hematopoiesis	J:48193
	abnormal granulocyte differentiation	J:48193
	abnormal lung morphology	J:48193
	abnormal lymphopoiesis	J:48193
	abnormal macrophage chemotaxis	J:48193
	abnormal monocyte differentiation	J:48193
	decreased body weight	J:48193
	decreased bone marrow cell number	J:48193
	decreased lymphocyte cell number	J:48193
	increased monocyte cell number	J:48193
	increased neutrophil cell number	J:48193
	increased spleen weight	J:48193
	premature death	J:48193
	spleen hyperplasia	J:48193
Inpp5d^tm1Wgk/Inpp5d^tm1.1Wgk Tg(Mx1-cre)1Cgn/0 B6.Cg-Inpp5d^tm1Wgk/Inpp5d^tm1.1Wgk Tg(Mx1-cre)1Cgn	abnormal leukocyte physiology	J:144110
	abnormal myeloid leukocyte morphology	J:144110
Inpp5d^tm1Wgk/Inpp5d^tm1Wgk Tg(Mx1-cre)1Cgn/0 B6.Cg-Inpp5d^tm1Wgk Tg(Mx1-cre)1Cgn	decreased susceptibility to graft versus host disease	J:144110

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 11/12/2024 MGI 6.24